Role of uric acid in multiple sclerosis
- PMID: 18219824
- DOI: 10.1007/978-3-540-73677-6_13
Role of uric acid in multiple sclerosis
Abstract
In the past decade, a growing number of evidence has implicated free radicals in a variety of pathophysiological conditions including aging, cancer, and coronary heart disease. Analyses of different aspects of multiple sclerosis (MS) pathology with respect to oxidative damage have also revealed evidence of free radical injury to the central nervous system (CNS), although attempts to protect the CNS using various antioxidants have met with only moderate success. Several recent studies have reported lower levels of uric acid (UA), a major scavenger of reactive nitrogen species, in MS patients, while other studies found no such correlation. Here, we discuss these studies as well as current efforts to manipulate serum UA levels in MS patients.
Similar articles
-
[Uric acid and multiple sclerosis].Ther Umsch. 2004 Sep;61(9):553-5. doi: 10.1024/0040-5930.61.9.553. Ther Umsch. 2004. PMID: 15493114 Review. German.
-
Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors.Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16303-8. doi: 10.1073/pnas.212645999. Epub 2002 Nov 25. Proc Natl Acad Sci U S A. 2002. PMID: 12451183 Free PMC article.
-
The treatment of multiple sclerosis with inosine.J Altern Complement Med. 2009 Jun;15(6):609. doi: 10.1089/acm.2009.0104. J Altern Complement Med. 2009. PMID: 19500009 No abstract available.
-
Modulation of serum uric acid levels by inosine in patients with multiple sclerosis does not affect blood pressure.J Hum Hypertens. 2010 May;24(5):359-62. doi: 10.1038/jhh.2009.83. Epub 2009 Oct 29. J Hum Hypertens. 2010. PMID: 19865105 Clinical Trial.
-
Uric acid in multiple sclerosis.Neurol Res. 2006 Apr;28(3):316-9. doi: 10.1179/016164106X98215. Neurol Res. 2006. PMID: 16687059 Review.
Cited by
-
Inosine in Neurodegenerative Diseases: From the Bench to the Bedside.Molecules. 2022 Jul 21;27(14):4644. doi: 10.3390/molecules27144644. Molecules. 2022. PMID: 35889517 Free PMC article. Review.
-
Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015-2020.Drugs. 2021 Jun;81(9):1031-1063. doi: 10.1007/s40265-021-01526-w. Epub 2021 Jun 4. Drugs. 2021. PMID: 34086251 Free PMC article. Review.
-
Inosine - a Multifunctional Treatment for Complications of Neurologic Injury.Cell Physiol Biochem. 2018;49(6):2293-2303. doi: 10.1159/000493831. Epub 2018 Sep 27. Cell Physiol Biochem. 2018. PMID: 30261493 Free PMC article. Review.
-
GWAS and transcriptional analysis prioritize ITPR1 and CNTN4 for a serum uric acid 3p26 QTL in Mexican Americans.BMC Genomics. 2016 Apr 2;17:276. doi: 10.1186/s12864-016-2594-5. BMC Genomics. 2016. PMID: 27039371 Free PMC article.
-
Is a hypothetical melanoma-like neuromelanin the underlying factor essential for the aetiopathogenesis and clinical manifestations of multiple sclerosis?BMC Neurol. 2013 Jul 18;13:91. doi: 10.1186/1471-2377-13-91. BMC Neurol. 2013. PMID: 23865526 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous